ACAD earnings
Acadia Pharmaceuticals (ACAD) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ACAD earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | 0.18 | 0.07 | 164.12% | $307.96M |
| Q1 2026 | May 6, 2026 | 0.02 | 0.04 | -50.00% | $268.06M |
| Q4 2025 | Feb 25, 2026 | 1.60 | 0.14 | 1067.88% | $283.99M |
| Q3 2025 | Nov 5, 2025 | 0.42 | 0.14 | 200.00% | $278.63M |
| Q2 2025 | Aug 6, 2025 | 0.16 | 0.14 | 14.29% | $264.57M |
| Q1 2025 | May 7, 2025 | 0.11 | 0.10 | 10.00% | $244.32M |
| Q4 2024 | Feb 26, 2025 | 0.86 | 0.19 | 352.63% | $259.60M |
| Q3 2024 | Nov 6, 2024 | 0.20 | 0.14 | 42.86% | $250.40M |
| Q2 2024 | Aug 6, 2024 | 0.20 | 0.18 | 11.11% | $241.96M |
| Q1 2024 | May 8, 2024 | 0.10 | 0.05 | 100.00% | $205.83M |
| Q4 2023 | Feb 27, 2024 | 0.28 | 0.30 | -6.67% | $231.04M |
| Q3 2023 | Nov 2, 2023 | -0.40 | -0.43 | 6.98% | $211.70M |
| Aug 2, 2023 | 0.01 | -0.12 | 108.33% | – | |
| May 8, 2023 | -0.27 | -0.21 | -28.57% | – | |
| Feb 27, 2023 | -0.26 | -0.25 | -4.00% | – | |
| Nov 2, 2022 | -0.17 | -0.18 | 5.56% | – | |
| Aug 8, 2022 | -0.21 | -0.25 | 16.00% | – | |
| May 4, 2022 | -0.70 | -0.49 | -42.86% | – | |
| Feb 28, 2022 | -0.27 | -0.24 | -12.50% | – | |
| Nov 8, 2021 | -0.09 | -0.27 | 66.67% | – |
- ACAD reports next on Nov 4, 2026, with EPS of 0.20 expected.
- ACAD beat EPS estimates in 55 of its last 89 reports.
Updated 2026-11-03 00:45 UTC